---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-014316"
form_type: "8-K"
ticker: "CPHI"
cik: "0001106644"
company_name: "CHINA PHARMA HOLDINGS, INC."
filed_at: "2023-02-24T23:59:59+00:00"
generated_at: "2026-06-19T00:27:55.932192+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# China Pharma Holdings announces 1-for-10 reverse stock split effective March 6, 2023

## Summary
- Reverse stock split at 1-for-10 ratio, effective March 6, 2023, trading begins on split-adjusted basis at market open.
- Every 10 existing shares convert into 1 share; fractional shares rounded up to whole number.
- Approved by Board and stockholders at Annual Meeting on December 27, 2022.
- Trading symbol remains 'CPHI' on NYSE American; new CUSIP number 16941T-203.
- Reverse stock split does not alter any stockholder's percentage interest except for fractional share adjustments.

## SEC filing metadata
- accession: 0001213900-23-014316
- form_type: 8-K
- ticker: CPHI
- cik: 0001106644
- company_name: CHINA PHARMA HOLDINGS, INC.
- filed_at: 2023-02-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/0001213900-23-014316-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1106644/000121390023014316/ea174228-8k_chinapharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-014316
- JSON: https://secwatch.observer/filing/0001213900-23-014316.json
- Plain text: https://secwatch.observer/filing/0001213900-23-014316.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.